Practical recommendations for the management of cardiovascular risk associated with atherogenic dyslipidemia, with special attention to residual risk. Spanish adaptation of a European Consensus of Experts
Articles > Article · 2017
Authors: Juan F. Ascaso, Mariano Blasco, Angel Brea, Angel Diaz, Antonio Hernandez Mijares, Teresa Mantilla, Jesus Millan, Juan Pedro-Botet, Xavier Pinto, Roberto Ferrari, Carlos Aguiar, Eduardo Alegria, Riccardo C. Bonadonna, Francesco Cosentino, Moses Elisaf, Michel Farnier, Jean Ferrieres, Pasquale Perrone Filardi, Nicolae Hancu, Latife Meral KAYIKÇIOĞLU, Alberto Mello e Silva, Jesus Millana, Zeljko Reiner, Lale Tokgozoglu, Paul Valensi, Margus Viigimaa, Michal Vrablik, Alberto Zambon, Jose Luis Zamorano, Alberico L. Catapano
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, Journal Indexed in AHCI, International, 2017, vol 29, pp 168-177
DOI: 10.1016/j.arteri.2016.12.001
Summary
This document has discussed clinical approaches to managing cardiovascular risk in clinical practice, with special focus on residual cardiovascular risk associated with lipid abnormalities, especially atherogenic dyslipidaemia (AD).